Akorn India

Gurugram, India Founded: 2011 • Age: 15 yrs Acquired By Biological E
Sterile pharmaceuticals are developed, manufactured, and marketed by Akorn India.
Request Access

About Akorn India

Akorn India is a company based in Gurugram (India) founded in 2011 was acquired by Biological E in August 2020.. The company has 3 employees as of March 31, 2025. Akorn India operates in a competitive market with competitors including Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others.

  • Headquarter Gurugram, India
  • Employees 3 as on 31 Mar, 2025
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Be Pharmaceuticals Private Limited
  • Date of Incorporation 29 Aug, 2011
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $89.4 K (USD)
    8.85
    as on Mar 31, 2024
  • Net Profit
    $9.63 K (USD)
    381.89
    as on Mar 31, 2024
  • EBITDA
    $-58.36 K (USD)
    10.03
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    3

    as on Mar 31, 2025

  • Acquired by
    Biological E

    (Aug 17, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Akorn India

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Akorn India

Akorn India has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biological E. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Vaccines and therapeutics for multiple diseases are developed and marketed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Akorn India

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Akorn India

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Akorn India Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Akorn India

Akorn India operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gland Pharma, Exela Pharma, Luoxin Pharmaceutical Group, Summit Biosciences and ApiJect, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Generic injectable drugs are manufactured across therapeutic segments.
domain founded_year HQ Location
Sterile injectable pharmaceuticals are manufactured alongside CDMO services.
domain founded_year HQ Location
Developer and manufacturer of pharmaceutical products
domain founded_year HQ Location
Nasal spray drug products are developed, manufactured, and commercialized.
domain founded_year HQ Location
Medicine injectors are manufactured by ApiJect for medical applications.
domain founded_year HQ Location
Diversified research services for clinical solutions are offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Akorn India

Frequently Asked Questions about Akorn India

When was Akorn India founded?

Akorn India was founded in 2011.

Where is Akorn India located?

Akorn India is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

How many employees does Akorn India have?

As of Mar 31, 2025, the latest employee count at Akorn India is 3.

What is the annual revenue of Akorn India?

Annual revenue of Akorn India is $89.4K as on Mar 31, 2024.

What does Akorn India do?

Akorn India, a subsidiary of Akorn, (a US-based pharma company) is engaged in the development, manufacturing, and marketing of sterile pharmaceuticals. Their portfolio includes general injectables, cephalosporins, carbapenems, and hormones. The company sells its branded products in Asia, LATAM, CIS, Africa, and the Middle East regions. The company claims to be one of the largest manufacturers of small volume sterile parenterals and antibacterial parenterals in India. Their capabilities include analytical method development and validation, stability services, global regulatory support, and process development, among others.

Who are the top competitors of Akorn India?

Akorn India's top competitors include Exela Pharma, Gland Pharma and Luoxin Pharmaceutical Group.

Who are Akorn India's investors?

Akorn India has 1 investor. Key investors include Biological E.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available